Krystal Biotech stock price target raised to $255 from $182 at BofA
PositiveFinancial Markets

Krystal Biotech has received a significant boost in its stock price target, now set at $255, up from $182, according to Bank of America. This upgrade reflects growing confidence in the company's potential and could attract more investors, signaling a positive outlook for the biotech sector.
— Curated by the World Pulse Now AI Editorial System